氯丙嗪双侧内关穴位注射治疗脑卒中顽固性呃逆临床研究  

Clinical study on intractable hiccup in post-stroke patients treated with bilateral neiguan acupoint injection by chlorpromazine

作　　者：彭祥来 林志忠 柳淑仪 

机构地区：[1]广东汕尾市人民医院,汕尾516600

出　　处：《中国实用神经疾病杂志》2015年第5期39-40,共2页Chinese Journal of Practical Nervous Diseases

基　　金：2013年度汕尾市医药科技计划项目(编号2013C025)

摘　　要：目的探讨氯丙嗪双侧内关穴位注射治疗脑卒中顽固性呃逆的临床效果。方法选取2011-01—2014-12我院脑卒中顽固性呃逆患者160例作为研究对象,随机分为观察组和对照组,对照组给予常规治疗,观察组给予氯丙嗪双侧内关穴位注射。对比2组治疗效果和患者满意度。结果观察组治愈率显著高于对照组,差异有统计学意义(P<0.05)。观察组总体满意率高达93.75%,显著高于对照组的77.50%,差异有统计学意义(P<0.05)。结论应用氯丙嗪双侧内关穴位注射治疗脑卒中顽固性呃逆,能够有效提高治疗效果和患者满意度。Objective To investigate the clinical effect on intractable hiccup in post‐stroke patients treated with bilateral neiguan acupoint injection by chlorpromazine. Methods 160 cases of post‐stroke patients with intractable hiccups treated in our hospital from January 2011 to December 2014 were enrolled. All patients were randomly divided into observation group and control group ,the control group received conventional therapy ,while observation group were given bilateral neiguan acupoint injection by chlorpromazine. The clinical effect and patients＇satisfaction were compared.Results The cure rate in chlorproma‐zine group was significantly higher ,and inefficiency rate was significantly lower than that in the control group. The difference of therapeutic effect between the two groups was statistically significant （P〈0.05）. Overall satisfaction rate of observation group was 93.75% ,which was significantly higher than 77.50% in control group（P〈0.05）. Conclusion Intractable hiccup in post‐stroke patients treated with bilateral neiguan acupoint injection by chlorpromazine can effectively improve the therapeutic efficacy and patients＇satisfaction.

关 键 词：氯丙嗪 穴位注射 脑卒中 顽固性呃逆 

分 类 号：R743.3[医药卫生—神经病学与精神病学]